NUS Stock Chart & Stats
$103.50
$0.00(0.00%)
At close: 4:00 PM EDT
$103.50
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$100.09 - $200.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$4.45B
Enterprise Value$437.00
Total Cash (Recent Filing)$200.41M
Total Debt (Recent Filing)$277.61M
Price to Earnings (P/E)4.7
Beta0.96
Next Earnings
Aug 10, 2026EPS Estimate
3.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.12
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.59
Price to Sales (P/S)0.32
P/FCF Ratio10.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Direct-selling NetworkNu Skin's multi-level direct-selling model creates durable distributor-driven distribution and recurring purchase behavior across skincare and nutrition. This network effect supports customer acquisition, repeat consumption, and localized scale in emerging markets, underpinning predictable revenue streams and go-to-market leverage over the medium term.
Balance Sheet DeleveragingMeaningfully lower leverage and a sizable equity base reduce refinancing and liquidity risk, improving financial flexibility. Combined with refinancing that extends maturities through 2031, the stronger balance sheet supports continued investments, share returns, and resilience to cyclical revenue pressure without forcing near-term distress financing.
Product & Data Differentiation (Prysm IO / LifePak)Early scale in Prysm iO scans and certified-product outperformance indicate a measurement-driven wellness ecosystem. Subscription growth and stronger LifePak sales show product-market fit and potential for higher lifetime value. The data footprint and certification strategy can create a durable competitive edge and recurring revenue bias.
Bears Say
Revenue DeclineA multi-year revenue contraction undermines operating leverage and constrains the firm's ability to scale fixed-cost investments. Persisting top-line decline pressures distributor morale and recruitment, weakens pricing power, and makes sustained margin recovery harder without structural improvements in customer acquisition or market expansion execution.
Margin Pressure From Selling CostsRising selling expenses and a material fall in operating margin indicate the company is investing heavily to drive leader productivity and new initiatives. If selling costs remain elevated relative to revenue, margin recovery may be delayed; sustained higher compensation levels could structurally compress profitability absent sustained revenue growth.
Weaker Cash ConversionDeclining free cash flow and low operating-cash-to-income conversion suggest working-capital drag or higher cash outlays. Weaker cash conversion limits the firm's capacity to self-fund growth initiatives, dividends, or buybacks, increasing reliance on the balance sheet and reducing margin for error if revenues remain pressured.
Nu Skin News
NUS FAQ
What was Nu Skin Enterprises’s price range in the past 12 months?
Nu Skin Enterprises lowest stock price was $100.09 and its highest was $200.00 in the past 12 months.
What is Nu Skin Enterprises’s market cap?
Nu Skin Enterprises’s market cap is $4.45B.
When is Nu Skin Enterprises’s upcoming earnings report date?
Nu Skin Enterprises’s upcoming earnings report date is Aug 10, 2026 which is in 11 days.
How were Nu Skin Enterprises’s earnings last quarter?
Nu Skin Enterprises released its earnings results on May 07, 2026. The company reported $2.442 earnings per share for the quarter, missing the consensus estimate of $2.616 by -$0.174.
Is Nu Skin Enterprises overvalued?
According to Wall Street analysts Nu Skin Enterprises’s price is currently Overvalued.
Does Nu Skin Enterprises pay dividends?
Nu Skin Enterprises does not currently pay dividends.
What is Nu Skin Enterprises’s EPS estimate?
Nu Skin Enterprises’s EPS estimate is 3.49.
How many shares outstanding does Nu Skin Enterprises have?
Currently, no data Available
What happened to Nu Skin Enterprises’s price movement after its last earnings report?
Nu Skin Enterprises reported an EPS of $2.442 in its last earnings report, missing expectations of $2.616. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nu Skin Enterprises?
Currently, no hedge funds are holding shares in MX:NUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nu Skin Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
MX:NUS Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $314.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.69%
12-Months-Change
Fundamentals
Return on Equity
4.15%
Trailing 12-Months
Asset Growth
-1.05%
Trailing 12-Months
Company Description
Nu Skin Enterprises
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
NUS Company Deck
NUS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced meaningful early strategic progress (Prysm iO data scale, subscription growth, LifePak +10% growth, regional momentum, and a strengthened balance sheet) against near-term profitability pressures (operating margin decline, higher selling expense, macro and transition costs). Management maintained guidance, signaled sequential improvement for Q2, and emphasized disciplined execution while investing in long-term growth initiatives.View all MX:NUS earnings summaries